{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:14:24Z","timestamp":1784740464366,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272844 and 81627901"],"award-info":[{"award-number":["82272844 and 81627901"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272844 and 81627901"],"award-info":[{"award-number":["82272844 and 81627901"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03635-0","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T05:45:09Z","timestamp":1755841509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Obesity enhances ovarian cancer chemotherapy efficacy through C1q-mediated tumor targeting and immune activation"],"prefix":"10.1186","volume":"23","author":[{"given":"Shiyi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhuang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuying","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"3635_CR1","doi-asserted-by":"publisher","first-page":"20220141","DOI":"10.1002\/EXP.20220141","volume":"3","author":"G Li","year":"2023","unstructured":"Li G, Song Z, Ru Y, Zhang J, Luo L, Yang W, Wu H, Jin H, Bao X, Wei D, Yan Z, Qu H, Zhu Z, Xue X, Zhou G. Small-molecule nanoprodrug with high drug loading and EGFR, PI3K\/AKT dual-inhibiting properties for bladder cancer treatment. Exploration. 2023;3:20220141.","journal-title":"Exploration"},{"key":"3635_CR2","first-page":"20210003","volume":"1","author":"J Liu","year":"2021","unstructured":"Liu J, Chen C, Wei T, Gayet O, Loncle C, Borge L, Dusetti N, Ma X, Marson D, Laurini E, Pricl S, Gu Z, Iovanna J, Peng L, Liang XJ. Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer. Exploration. 2021;1:20210003.","journal-title":"Exploration"},{"key":"3635_CR3","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","volume":"1","author":"EJ Kuipers","year":"2015","unstructured":"Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJH, Watanabe T. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"3635_CR4","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S1470-2045(24)00313-9","volume":"25","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang X, Jiang S, Mo M, Wang Q, Wang Y, Zhou L, Hu S, Yang H, Hou Y, Chen Y, Lu X, Wang Y, Zhou X, Li W, Chang C, Yang X, Chen K, Cao J, Xu Q, Sun Y, Luo J, Luo Z, Hu X. Site-specific therapy guided by a 90-gene expression assay versus empirical chemotherapy in patients with cancer of unknown primary (Fudan CUP-001): a randomised controlled trial. Lancet Oncol. 2024;25(8):1092\u2013102.","journal-title":"Lancet Oncol"},{"issue":"8","key":"3635_CR5","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1039\/D2CS00757F","volume":"52","author":"K Peng","year":"2023","unstructured":"Peng K, Zheng Y, Xia W, Mao Z-W. Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses. Chem Soc Rev. 2023;52(8):2790\u2013832.","journal-title":"Chem Soc Rev"},{"issue":"2","key":"3635_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz Y. Doxil\u00ae--the first FDA-approved nano-drug: lessons learned. J Control Release. 2012;160(2):117\u201334.","journal-title":"J Control Release"},{"issue":"24","key":"3635_CR7","doi-asserted-by":"publisher","first-page":"9693","DOI":"10.1002\/anie.202002306","volume":"59","author":"B Yang","year":"2020","unstructured":"Yang B, Chen Y, Shi J. Tumor-specific chemotherapy by nanomedicine-enabled differential stress sensitization. Angew Chem Int Ed Engl. 2020;59(24):9693\u2013701.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"3635_CR8","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1038\/s41467-021-23230-9","volume":"12","author":"MJ Hajipour","year":"2021","unstructured":"Hajipour MJ, Aghaverdi H, Serpooshan V, Vali H, Sheibani S, Mahmoudi M. Sex as an important factor in nanomedicine. Nat Commun. 2021;12(1):2984.","journal-title":"Nat Commun"},{"issue":"2","key":"3635_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41565-023-01502-3","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Deng W, Lee D, Yan L, Lu Y, Dong S, Huntoon K, Antony A, Li X, Ye R, Zhao Y, Zhao F, Schrank BR, Ha J, Kang M, Yang M, Gong P, Lorenzi PL, Tan L, Gallup TD, Tang SK, Yang Z, Li J, Sanford NN, Wang H, Kim BYS, Jiang W. Age-associated disparity in phagocytic clearance affects the efficacy of cancer nanotherapeutics. Nat Nanotechnol. 2024;19(2):255\u201363.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"3635_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A, Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-O\u2019Connor DS, M\u00e9ndez-Lagares G, Tarantal AF, Isseroff RR, Griffith TS, Schalper KA, Merleev A, Saha A, Maverakis E, Kelly K, Aljumaily R, Ibrahimi S, Mukherjee S, Machiorlatti M, Vesely SK, Longo DL, Blazar BR, Canter RJ, Murphy WJ, Monjazeb AM. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint Blockade. Nat Med. 2019;25(1):141\u201351.","journal-title":"Nat Med"},{"issue":"11","key":"3635_CR11","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41565-021-01017-9","volume":"16","author":"EP Stater","year":"2021","unstructured":"Stater EP, Sonay AY, Hart C, Grimm J. The ancillary effects of nanoparticles and their implications for nanomedicine. Nat Nanotechnol. 2021;16(11):1180\u201394.","journal-title":"Nat Nanotechnol"},{"issue":"6","key":"3635_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41565-021-00924-1","volume":"16","author":"KE Wheeler","year":"2021","unstructured":"Wheeler KE, Chetwynd AJ, Fahy KM, Hong BS, Tochihuitl JA, Foster LA, Lynch I. Environmental dimensions of the protein corona. Nat Nanotechnol. 2021;16(6):617\u201329.","journal-title":"Nat Nanotechnol"},{"key":"3635_CR13","doi-asserted-by":"publisher","first-page":"114356","DOI":"10.1016\/j.addr.2022.114356","volume":"186","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, Zoulikha M, Qiu M, Teng C, Lin C, Li X, Sallam MA, Xu Q, He W. The effects of protein Corona on in vivo fate of nanocarriers. Adv Drug Deliv Rev. 2022;186:114356.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"3635_CR14","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1038\/s41467-018-06979-4","volume":"9","author":"JY Oh","year":"2018","unstructured":"Oh JY, Kim HS, Palanikumar L, Go EM, Jana B, Park SA, Kim HY, Kim K, Seo JK, Kwak SK, Kim C, Kang S, Ryu J. Cloaking nanoparticles with protein Corona shield for targeted drug delivery. Nat Commun. 2018;9(1):4548.","journal-title":"Nat Commun"},{"issue":"6","key":"3635_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.addr.2009.03.009","volume":"61","author":"P Aggarwal","year":"2009","unstructured":"Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev. 2009;61(6):428\u201337.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"3635_CR16","doi-asserted-by":"publisher","first-page":"15723","DOI":"10.1021\/acsnano.0c06679","volume":"14","author":"Y Ju","year":"2020","unstructured":"Ju Y, Kelly HG, Dagley LF, Reynaldi A, Schlub TE, Spall SK, Bell CA, Cui J, Mitchell AJ, Lin Z, Wheatley AK, Thurecht KJ, Davenport MP, Webb AI, Caruso F, Kent SJ. Person-specific biomolecular coronas modulate nanoparticle interactions with immune cells in human blood. ACS Nano. 2020;14(11):15723\u201337.","journal-title":"ACS Nano"},{"issue":"3","key":"3635_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1039\/C6BM00921B","volume":"5","author":"C Corbo","year":"2017","unstructured":"Corbo C, Molinaro R, Tabatabaei M, Farokhzad OC, Mahmoudi M. Personalized protein corona on nanoparticles and its clinical implications. Biomater Sci. 2017;5(3):378\u201387.","journal-title":"Biomater Sci"},{"issue":"9","key":"3635_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrclinonc.2013.120","volume":"10","author":"W Tao","year":"2013","unstructured":"Tao W, Lagergren J. Clinical management of obese patients with cancer. Nat Rev Clin Oncol. 2013;10(9):519\u201333.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"3635_CR19","first-page":"88","volume":"69","author":"H Sung","year":"2019","unstructured":"Sung H, Siegel RL, Torre LA, Pearson-Stuttard J, Islami F, Fedewa SA, Goding Sauer A, Shuval K, Gapstur SM, Jacobs EJ, Giovannucci EL, Jemal A. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin. 2019;69(2):88\u2013112.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3635_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10555-010-9252-1","volume":"29","author":"ME Grossmann","year":"2010","unstructured":"Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, Cleary MP. Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev. 2010;29(4):641\u201353.","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"3635_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1200\/JCO.2008.17.9945","volume":"27","author":"BM Wolpin","year":"2009","unstructured":"Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, Wu K, Pollak MN, Giovannucci EL, Fuchs CS. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol. 2009;27(2):176\u201385.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3635_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/annonc\/mdt481","volume":"25","author":"L Weiss","year":"2014","unstructured":"Weiss L, Melchardt T, Habringer S, Boekstegers A, Hufnagl C, Neureiter D, Hopfinger G, Greil R, Egle A. Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma. Ann Oncol. 2014;25(1):171\u20136.","journal-title":"Ann Oncol"},{"issue":"4","key":"3635_CR23","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.cell.2020.03.062","volume":"181","author":"KM Chung","year":"2020","unstructured":"Chung KM, Singh J, Lawres L, Dorans KJ, Garcia C, Burkhardt DB, Robbins R, Bhutkar A, Cardone R, Zhao X, Babic A, Vayrynen SA, Dias Costa A, Nowak JA, Chang DT, Dunne RF, Hezel AF, Koong AC, Wilhelm JJ, Bellin MD, Nylander V, Gloyn AL, McCarthy MI, Kibbey RG, Krishnaswamy S, Wolpin BM, Jacks T, Fuchs CS, Muzumdar MD. Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma. Cell. 2020;181(4):832\u201347.","journal-title":"Cell"},{"issue":"9","key":"3635_CR24","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1097\/IGC.0b013e31822d2aa3","volume":"21","author":"FJ Backes","year":"2011","unstructured":"Backes FJ, Nagel CI, Bussewitz E, Donner J, Hade E, Salani R. The impact of body weight on ovarian cancer outcomes. Int J Gynecol Cancer. 2011;21(9):1601\u20135.","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"3635_CR25","doi-asserted-by":"publisher","first-page":"109285","DOI":"10.1016\/j.celrep.2021.109285","volume":"35","author":"AK Pingili","year":"2021","unstructured":"Pingili AK, Chaib M, Sipe LM, Miller EJ, Teng B, Sharma R, Yarbro JR, Asemota S, Al Abdallah Q, Mims TS, Marion TN, Daria D, Sekhri R, Hamilton AM, Troester MA, Jo H, Choi HY, Hayes DN, Cook KL, Narayanan R, Pierre JF, Makowski L. Immune checkpoint Blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer. Cell Rep. 2021;35(12):109285.","journal-title":"Cell Rep"},{"key":"3635_CR26","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"3635_CR27","first-page":"389","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nature reviews. Clin Oncol. 2024;21(5):389\u2013400.","journal-title":"Clin Oncol"},{"issue":"4","key":"3635_CR28","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1021\/acsami.1c22432","volume":"14","author":"W Zuo","year":"2022","unstructured":"Zuo W, Chen W, Liu J, Huang S, Chen L, Liu Q, Liu N, Jin Q, Li Y, Wang P, Zhu X. Macrophage-mimic Hollow mesoporous Fe-based nanocatalysts for self-amplified chemodynamic therapy and metastasis Inhibition via tumor microenvironment remodeling. ACS Appl Mater Interfaces. 2022;14(4):5053\u201365.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"3635_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11302-018-9641-4","volume":"15","author":"Y Huang","year":"2019","unstructured":"Huang Y, Gu Z, Fan Y, Zhai G, Zhao X, Sun Q, Shi Y, Lin G. Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future. Purinergic Signal. 2019;15(1):53\u201367.","journal-title":"Purinergic Signal"},{"key":"3635_CR30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jconrel.2019.10.052","volume":"316","author":"Y Huang","year":"2019","unstructured":"Huang Y, Shi Y, Wang Q, Qi T, Fu X, Gu Z, Zhang Y, Zhai G, Zhao X, Sun Q, Lin G. Enzyme responsiveness enhances the specificity and effectiveness of nanoparticles for the treatment of B16F10 melanoma. J Control Release. 2019;316:208\u201322.","journal-title":"J Control Release"},{"issue":"1","key":"3635_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15212\/bioi-2024-0002","volume":"5","author":"J Trivedi","year":"2024","unstructured":"Trivedi J, Yasir M, Maurya RK, Tripathi AS. Aptamer-based theranostics in oncology: design strategies and limitations. BIOI. 2024;5(1):7.","journal-title":"BIOI"},{"issue":"1","key":"3635_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.42671","volume":"76","author":"PA Monach","year":"2024","unstructured":"Monach PA, Complement. Arthritis Rheumatol. 2024;76(1):1\u20138.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"3635_CR33","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1172\/JCI90962","volume":"127","author":"V Afshar-Kharghan","year":"2017","unstructured":"Afshar-Kharghan V. The role of the complement system in cancer. J Clin Invest. 2017;127(3):780\u20139.","journal-title":"J Clin Invest"},{"issue":"2","key":"3635_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molimm.2014.06.011","volume":"61","author":"EIB Peerschke","year":"2014","unstructured":"Peerschke EIB, Ghebrehiwet B. cC1qR\/CR and gC1qR\/p33: observations in cancer. Mol Immunol. 2014;61(2):100\u20139.","journal-title":"Mol Immunol"},{"issue":"6","key":"3635_CR35","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1182\/blood-2011-07-369728","volume":"120","author":"KK Hosszu","year":"2012","unstructured":"Hosszu KK, Valentino A, Vinayagasundaram U, Vinayagasundaram R, Joyce MG, Ji Y, Peerschke EI, Ghebrehiwet B. DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells. Blood. 2012;120(6):1228\u201336.","journal-title":"Blood"},{"issue":"1","key":"3635_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12974-016-0641-4","volume":"13","author":"M Sherman","year":"2016","unstructured":"Sherman M, Liu MM, Birnbaum S, Wolf SE, Minei JP, Gatson JW. Adult obese mice suffer from chronic secondary brain injury after mild TBI. J Neuroinflammation. 2016;13(1):171.","journal-title":"J Neuroinflammation"},{"key":"3635_CR37","doi-asserted-by":"publisher","first-page":"134734","DOI":"10.1016\/j.foodchem.2022.134734","volume":"404","author":"W Jiao","year":"2023","unstructured":"Jiao W, Sang Y, Wang X, Wang S. Metabonomics and the gut Microbiome analysis of the effect of 6-shogaol on improving obesity. Food Chem. 2023;404:134734. Pt B).","journal-title":"Food Chem"},{"issue":"6","key":"3635_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1139\/apnm-2013-0403","volume":"39","author":"CMM Prado","year":"2014","unstructured":"Prado CMM, Baracos VE, Xiao J, Birdsell L, StuyckensKim, Park YC, Parekh T, Sawyer MB. The association between body composition and toxicities from the combination of doxil and trabectedin in patients with advanced relapsed ovarian cancer. Appl Physiol Nutr Me. 2014;39(6):693\u20138.","journal-title":"Appl Physiol Nutr Me"},{"issue":"1","key":"3635_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B. T cells in health and disease. Signal Transduct Target Ther. 2023;8(1):235.","journal-title":"Signal Transduct Target Ther"},{"issue":"15","key":"3635_CR40","doi-asserted-by":"publisher","first-page":"10478","DOI":"10.1021\/jacs.3c14046","volume":"146","author":"Y Cong","year":"2024","unstructured":"Cong Y, Qiao R, Wang X, Ji Y, Yang J, Baimanov D, Yu S, Cai R, Zhao Y, Wu X, Chen C, Wang L. Protein Corona-mediated Inhibition of nanozyme activity: impact of protein shape. J Am Chem Soc. 2024;146(15):10478\u201388.","journal-title":"J Am Chem Soc"},{"key":"3635_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jconrel.2024.02.020","volume":"368","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xiao W, He S, Xia X, Yang W, Yang Z, Hu H, Wang Y, Wang X, Li H, Huang Y, Gao H. Lipid-mediated protein corona regulation with increased Apolipoprotein A-I recruitment for glioma targeting. J Control Release. 2024;368:42\u201351.","journal-title":"J Control Release"},{"issue":"3","key":"3635_CR42","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s42255-019-0041-z","volume":"1","author":"LG Straub","year":"2019","unstructured":"Straub LG, Scherer PE. Metabolic messengers: adiponectin. Nat Metab. 2019;1(3):334\u20139.","journal-title":"Nat Metab"},{"issue":"6","key":"3635_CR43","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.194.6.781","volume":"194","author":"CA Ogden","year":"2001","unstructured":"Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, Henson PM. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194(6):781\u201395.","journal-title":"J Exp Med"},{"issue":"11","key":"3635_CR44","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nrn2394","volume":"9","author":"VH Perry","year":"2008","unstructured":"Perry VH, O\u2019Connor V. C1q: the perfect complement for a synaptic feast? Nat Rev Neurosci. 2008;9(11):807\u201311.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"3635_CR45","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nnano.2015.330","volume":"11","author":"S Sch\u00f6ttler","year":"2016","unstructured":"Sch\u00f6ttler S, Becker G, Winzen S, Steinbach T, Mohr K, Landfester K, Mail\u00e4nder V, Wurm FR. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat Nanotechnol. 2016;11(4):372\u20137.","journal-title":"Nat Nanotechnol"},{"issue":"45","key":"3635_CR46","doi-asserted-by":"publisher","first-page":"e2211980","DOI":"10.1002\/adma.202211980","volume":"35","author":"H Liu","year":"2023","unstructured":"Liu H, Xu S, Yong T, Wei Z, Bie N, Zhang X, Li X, Li J, Li S, Wang S, Zhao Y, Yang X, Gan L. Hydrophobicity-adaptive polymers trigger fission of tumor-cell-derived microparticles for enhanced anticancer drug delivery. Adv Mater. 2023;35(45):e2211980.","journal-title":"Adv Mater"},{"issue":"1","key":"3635_CR47","doi-asserted-by":"publisher","first-page":"10400","DOI":"10.1038\/s41467-024-54810-0","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Wu W, Liu Q, Wu Q, Ren P, Xi X, Liu H, Zhao J, Zhang W, Wang Z, Lv Y, Tian B, Sun S, Cui J, Zhao Y, Wu J, Gao M, Chen F. Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia immunity. Nat Commun. 2024;15(1):10400.","journal-title":"Nat Commun"},{"issue":"1","key":"3635_CR48","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41467-024-45254-7","volume":"15","author":"Y Miao","year":"2024","unstructured":"Miao Y, Li L, Wang Y, Wang J, Zhou Y, Guo L, Zhao Y, Nie D, Zhang Y, Zhang X, Gan Y. Regulating protein corona on nanovesicles by glycosylated polyhydroxy polymer modification for efficient drug delivery. Nat Commun. 2024;15(1):1159.","journal-title":"Nat Commun"},{"issue":"2","key":"3635_CR49","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1172\/JCI94586","volume":"128","author":"DMS Hossain","year":"2018","unstructured":"Hossain DMS, Javaid S, Cai M, Zhang C, Sawant A, Hinton M, Sathe M, Grein J, Blumenschein W, Pinheiro EM, Chackerian A. Dinaciclib induces Immunogenic cell death and enhances anti-PD1-mediated tumor suppression. J Clin Invest. 2018;128(2):644\u201354.","journal-title":"J Clin Invest"},{"issue":"2","key":"3635_CR50","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/sj.cr.7310021","volume":"16","author":"EY Chung","year":"2006","unstructured":"Chung EY, Kim SJ, Ma XJ. Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res. 2006;16(2):154\u201361.","journal-title":"Cell Res"},{"issue":"7234","key":"3635_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nature07781","volume":"458","author":"MB Torchinsky","year":"2009","unstructured":"Torchinsky MB, Garaude J, Martin AP, Blander JM. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature. 2009;458(7234):78\u201382.","journal-title":"Nature"},{"issue":"3","key":"3635_CR52","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S1568-9972(02)00032-0","volume":"1","author":"V Pittoni","year":"2002","unstructured":"Pittoni V, Valesini G. The clearance of apoptotic cells: implications for autoimmunity. Autoimmun Rev. 2002;1(3):154\u201361.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"3635_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1189\/jlb.3A0614-278R","volume":"97","author":"EV Clarke","year":"2015","unstructured":"Clarke EV, Weist BM, Walsh CM, Tenner AJ. Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. J Leukoc Biol. 2015;97(1):147\u201360.","journal-title":"J Leukoc Biol"},{"issue":"7","key":"3635_CR54","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41581-023-00704-1","volume":"19","author":"EE West","year":"2023","unstructured":"West EE, Kemper C. Complosome - the intracellular complement system. Nat Rev Nephrol. 2023;19(7):426\u201339.","journal-title":"Nat Rev Nephrol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03635-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03635-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03635-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:16:23Z","timestamp":1757416583000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03635-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3635"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03635-0","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments received approval from the Institutional Animal Care and Use Committee at Tongji Medical College with an approval number: 4510.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final manuscript and the submission to this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"580"}}